Treatment Arm

Visit number vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
N Mean StdDev Median Min Max Unknown Total
Baseline Visit 163 46.3 ± 10.2 47.1 17.7 56.9 6 169
Month-6 Follow-up Visit 138 45.8 ± 10.4 47.1 17.7 56.9 31 169
Month-12 Follow-up Visit 77 47.0 ± 10.4 49.5 17.7 56.9 31 108
Treatment arm vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 163 46.3 ± 10.2 47.1 17.7 56.9 6 169
Conservative Medical Therapy (CMT) 43 45.9 ± 11.3 52.0 20.1 56.9 1 44
CMT + Sham CPAP 40 46.3 ± 9.1 47.1 29.9 56.9 2 42
CMT + Active CPAP 40 46.4 ± 10.4 47.1 17.7 56.9 2 42
CMT + Active CPAP + Motivational Enhancement 40 46.7 ± 10.1 48.3 17.7 56.9 1 41
Treatment arm vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 138 45.8 ± 10.4 47.1 17.7 56.9 31 169
Conservative Medical Therapy (CMT) 37 44.4 ± 10.9 44.6 17.7 56.9 7 44
CMT + Sham CPAP 33 46.0 ± 9.3 47.1 27.5 56.9 9 42
CMT + Active CPAP 35 48.3 ± 10.1 52.0 17.7 56.9 7 42
CMT + Active CPAP + Motivational Enhancement 33 44.5 ± 11.0 44.6 17.7 56.9 8 41
Treatment arm vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 77 47.0 ± 10.4 49.5 17.7 56.9 31 108
Conservative Medical Therapy (CMT) 21 49.2 ± 8.8 52.0 29.9 56.9 8 29
CMT + Sham CPAP 20 45.8 ± 9.5 47.1 29.9 56.9 7 27
CMT + Active CPAP 17 45.9 ± 12.1 49.5 17.7 56.9 9 26
CMT + Active CPAP + Motivational Enhancement 19 46.7 ± 11.9 49.5 22.6 56.9 7 26
Age at visit vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 163 46.3 ± 10.2 47.1 17.7 56.9 6 169
46.0 to 59.0 years 42 46.9 ± 10.5 49.5 17.7 56.9 1 43
59.0 to 66.0 years 38 45.6 ± 10.6 48.3 17.7 56.9 4 42
66.0 to 69.0 years 42 46.8 ± 10.3 49.5 20.1 56.9 - 42
70.0 to 76.0 years 41 45.9 ± 9.6 47.1 29.9 56.9 1 42
Age at visit vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 138 45.8 ± 10.4 47.1 17.7 56.9 31 169
46.0 to 60.0 years 29 42.6 ± 13.6 42.2 17.7 56.9 14 43
60.0 to 66.0 years 34 46.6 ± 9.0 43.4 27.5 56.9 8 42
66.0 to 70.0 years 39 47.6 ± 8.6 49.5 17.7 56.9 3 42
70.0 to 77.0 years 36 45.8 ± 10.1 47.1 22.6 56.9 6 42
Age at visit vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 77 47.0 ± 10.4 49.5 17.7 56.9 31 108
47.0 to 60.0 years 14 41.1 ± 13.0 40.9 17.7 56.9 13 27
60.0 to 66.0 years 21 48.5 ± 7.5 49.5 34.8 56.9 6 27
66.0 to 70.0 years 21 47.1 ± 11.3 52.0 22.6 56.9 6 27
71.0 to 77.0 years 21 49.2 ± 9.4 53.6 27.5 56.9 6 27
Gender vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 163 46.3 ± 10.2 47.1 17.7 56.9 6 169
Male 108 48.1 ± 9.6 52.0 17.7 56.9 2 110
Female 55 42.9 ± 10.6 42.2 17.7 56.9 4 59
Gender vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 138 45.8 ± 10.4 47.1 17.7 56.9 31 169
Male 94 47.3 ± 9.3 49.5 17.7 56.9 16 110
Female 44 42.7 ± 11.9 40.9 17.7 56.9 15 59
Gender vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 77 47.0 ± 10.4 49.5 17.7 56.9 31 108
Male 51 49.1 ± 9.0 52.0 27.5 56.9 21 72
Female 26 42.7 ± 12.0 44.6 17.7 56.9 10 36
Race vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 162 46.4 ± 10.2 48.3 17.7 56.9 6 168
White 148 46.3 ± 10.2 48.3 17.7 56.9 4 152
American Indian or Alaskan Native - - - - - - - -
Black or African American 9 46.8 ± 11.3 54.4 29.9 56.9 2 11
Asian 4 49.5 ± 9.4 52.0 37.3 56.9 - 4
Native Hawaiian or other Pacific islander - - - - - - - -
Other 1 42.2 - 42.2 42.2 42.2 - 1
Multiple - - - - - - - -
Race vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 137 45.9 ± 10.4 47.1 17.7 56.9 31 168
White 128 45.8 ± 10.4 47.1 17.7 56.9 24 152
American Indian or Alaskan Native - - - - - - - -
Black or African American 6 46.2 ± 12.5 50.7 27.5 56.9 5 11
Asian 3 47.9 ± 9.9 49.5 37.3 56.9 1 4
Native Hawaiian or other Pacific islander - - - - - - - -
Other - - - - - - 1 1
Multiple - - - - - - - -
Race vs Medical Outcomes Study SF-36: Role limitations due to physical problem subscale normal score
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 77 47.0 ± 10.4 49.5 17.7 56.9 31 108
White 71 46.9 ± 10.3 49.5 17.7 56.9 24 95
American Indian or Alaskan Native - - - - - - - -
Black or African American 5 45.1 ± 13.1 49.5 29.9 56.9 4 9
Asian 1 56.9 - 56.9 56.9 56.9 2 3
Native Hawaiian or other Pacific islander - - - - - - - -
Other - - - - - - 1 1
Multiple - - - - - - - -